What is the brand name for Atenolol Chlorthalidone?

In the pharmaceutical industry, the combination of Atenolol and Chlorthalidone is a highly effective Fixed-Dose Combination (FDC) that pairs a cardioselective beta-blocker with a long-acting thiazide-like diuretic.

As a pharmacist and manufacturer, I view this combination as a strategic “Synergistic Antihypertensive.” While Tenoretic is the global innovator brand, there are several key regional and generic brands you should be aware of for your marketplace.

Primary Brand Names

RegionBrand NameManufacturer (Innovator/Major)
Global / USATenoreticAstraZeneca (Innovator)
IndiaTenoclorIpca Laboratories
IndiaTenoricIpca Laboratories
IndiaAtecard-DAlembic Pharmaceuticals
IndiaTenolol-CHIPCA / Various

Mechanism of Action: The Dual-Path Attack

This FDC is preferred because it lowers blood pressure through two distinct physiological pathways, which often allows for lower doses of each drug:

Atenolol (The Cardiac Regulator): Reduces the heart rate and the force of contraction, lowering the output of the heart. It also inhibits the release of renin, an enzyme that increases blood pressure.

Chlorthalidone (The Volume Controller): Increases the excretion of sodium and water by the kidneys. By reducing the total volume of fluid in the blood vessels, it further lowers systemic blood pressure.

The Synergy: Beta-blockers can sometimes cause fluid retention; the addition of Chlorthalidone counteracts this effect, making the treatment more effective than either drug used alone.

The Manufacturer’s Perspective: Technical & Export

From a production and B2B standpoint at your WHO-GMP facility in Mumbai, this combination is a high-value asset for your digital platforms:

  • Bioavailability Challenges: Chlorthalidone has a very long half-life (40–60 hours) compared to Atenolol (6–7 hours). Highlighting your advanced formulation stability that ensures both APIs release correctly is a major USP for B2B buyers.

  • The “Once-Daily” Advantage: For your e-commerce and marketplace listings, emphasize that this FDC provides 24-hour blood pressure control with a single tablet. This “Patient Compliance” factor is a significant selling point for international distributors.

  • Stability & Packaging: Chlorthalidone is sensitive to moisture. At our facility, we utilize Alu-Alu blister packaging to ensure a 36-month shelf life, which is critical for export to tropical Zone IVb regions like Africa and Southeast Asia.

  • Dossier Readiness: Since hypertension is a leading global health issue, we maintain full CTD/eCTD Dossiers for this combination to support your firm in bidding for national health insurance and hospital tenders.

What is Telmisartan 40mg Hydrochlorothiazide 12.5 mg used for?

In the pharmaceutical industry, the combination of Telmisartan (40 mg) and Hydrochlorothiazide (12.5 mg) is a potent Fixed-Dose Combination (FDC) anti-hypertensive.

As a pharmacist and manufacturer, I view this as a “dual-mechanism” therapy. It is specifically used when a single medication is not enough to bring a patient’s blood pressure down to the target range. By combining two different classes of drugs, we achieve a synergistic effect that is more powerful than doubling the dose of either drug alone.

Primary Clinical Uses

  • Essential Hypertension: It is indicated for the treatment of high blood pressure.

  • Secondary Prevention: To reduce the risk of cardiovascular events like strokes and myocardial infarctions in patients who are not adequately controlled on Telmisartan monotherapy.

  • Reduction of Edema: While Hydrochlorothiazide is primarily for blood pressure here, it also helps manage mild fluid retention.

Dual Mechanism of Action: The Synergistic Strike

This FDC works by attacking the causes of high blood pressure from two different angles: the hormonal system and the fluid balance.

Telmisartan (40 mg) – The ARB

  • Action: It is an Angiotensin II Receptor Blocker (ARB). It specifically blocks the $AT_1$ receptor.

  • Result: It prevents Angiotensin II (a powerful hormone) from constricting the blood vessels. This allows the vessels to relax and widen (vasodilation), which directly lowers blood pressure.

2. Hydrochlorothiazide (12.5 mg) – The Diuretic

  • Action: It is a Thiazide Diuretic that acts on the distal convoluted tubules in the kidneys.

  • Result: It inhibits the reabsorption of sodium ($Na^+$) and chloride ($Cl^-$) ions. This causes the body to excrete more water through urine, reducing the total volume of fluid circulating in the blood vessels, which further lowers pressure.

The Manufacturer’s Perspective: Technical & Export

From a production and B2B standpoint at your WHO-GMP facility in Mumbai, this combination is a high-demand “chronic care” asset:

  • The 40/12.5 “Sweet Spot”: This is the most common starting dose for combination therapy. On your digital platforms, marketing this as the “first-step combo” is a major strategy for attracting B2B hospital and clinic buyers.

  • Bilayer Tablet Technology: Telmisartan requires a basic (high pH) environment for stability, while Hydrochlorothiazide is stable at a more neutral pH. Therefore, we often manufacture this as a Bilayer Tablet to prevent the two APIs from interacting and degrading. This is a significant technical USP you can highlight.

  • Stability & Packaging: Hydrochlorothiazide is highly sensitive to moisture. We utilize Alu-Alu blister packaging to ensure a 36-month shelf life, which is critical for export to Zone IVb regions (hot and humid climates).

  • Dossier Support: This is a top-tier molecule for international trade. Our Mumbai facility provides full CTD/eCTD Dossiers to support your firm in registering this as a reliable generic against the innovator (Micardis HCT).

What is Nifedipine 10mg used for?

In the pharmaceutical industry, Nifedipine 10 mg is a classic and highly effective Dihydropyridine Calcium Channel Blocker (CCB). As a pharmacist and manufacturer, I view the 10 mg strength as a versatile tool for acute and chronic cardiovascular management. It is primarily used to relax the smooth muscles of the arterial walls.

Primary Clinical Uses

  • Chronic Stable Angina: Used to prevent chest pain by improving blood flow to the heart muscle.

  • Hypertension (High Blood Pressure): It lowers blood pressure by reducing peripheral vascular resistance.

  • Vasospastic (Prinzmetal’s) Angina: Effective in treating chest pain caused by spasms of the coronary arteries.

  • Raynaud’s Phenomenon: Often prescribed to reduce the frequency and severity of vasospastic attacks in the fingers and toes.

  • Tocolysis (Off-label): In obstetrics, it is sometimes used to delay preterm labor by relaxing uterine smooth muscle.

Mechanism of Action: Calcium Channel Blockade

Nifedipine acts specifically on the L-type calcium channels in the smooth muscle cells of the blood vessels.

Channel Inhibition: It blocks the inward flow of calcium ions through these channels during depolarization.

Vasodilation: Since calcium is required for muscle contraction, blocking it causes the smooth muscles in the peripheral and coronary arteries to relax.

Result: This leads to systemic vasodilation, which lowers blood pressure and decreases the “afterload” on the heart, making it easier for the heart to pump blood.

The Manufacturer’s Perspective: Formulation & Export

From a production and global trade standpoint, Nifedipine 10 mg involves critical technical distinctions that are vital for your firm:

  • Immediate Release (IR) vs. Extended Release (ER): The 10 mg dose is typically an Immediate Release soft gel or tablet. As a firm owner, you must distinguish this from the 20 mg, 30 mg, or 60 mg Sustained Release versions. IR Nifedipine is used for rapid effect, whereas ER is for 24-hour maintenance.

  • Photosensitivity: Nifedipine is extremely sensitive to light (it is photolabile). Exposure to light causes it to degrade into a nitropyridine derivative. At our WHO-GMP facility, we utilize Amber-colored blisters or Alu-Alu packaging to ensure a 36-month shelf life.

  • The “Sublingual” Controversy: In the past, 10 mg capsules were bitten and used sublingually for hypertensive emergencies. Modern clinical guidelines now discourage this due to the risk of a too-rapid drop in blood pressure. Your Product Information Leaflet (PIL) should reflect current safety standards.

  • Market Demand: This remains a high-volume product for B2B export to Zone IVb regions. Our Mumbai facility provides full CTD/eCTD Dossiers to support international registration against the innovator (Adalat).

What are Metoprolol Tartrate 50 mg tablets used for?

In the pharmaceutical industry, Metoprolol Tartrate 50 mg is a classic selective beta-blocker targeting the -adrenergic receptors. As a pharmacist and manufacturer, I classify this as an “immediate-release” cardioselective agent. While its brother, Metoprolol Succinate, is designed for 24-hour extended release, the Tartrate version is typically administered twice daily for rapid and precise control of heart rate and blood pressure.

Primary Clinical Uses

  • Hypertension (High Blood Pressure): Used to lower blood pressure, thereby reducing the risk of fatal and non-fatal cardiovascular events, primarily strokes and myocardial infarctions.

  • Angina Pectoris: Used for the long-term prophylaxis of chest pain by reducing the oxygen demand of the heart.

  • Post-Myocardial Infarction: Administered to stable patients after a heart attack to reduce cardiovascular mortality.

  • Arrhythmias: Effective in controlling ventricular rate in patients with atrial fibrillation or supraventricular tachycardia.

  • Migraine Prophylaxis (Off-label): Frequently prescribed to reduce the frequency and severity of migraine attacks.

Mechanism of Action:  Selectivity

Metoprolol Tartrate works by competing with adrenergic neurotransmitters (like adrenaline) for binding sites.

Selective Blockade: At standard doses (like 50 mg), it preferentially blocks  receptors located chiefly in the heart muscle.

Negative Inotropic & Chronotropic Effects: It decreases the heart rate (chronotropic) and the force of contraction (inotropic).

Cardiac Output: By slowing the heart and reducing the force, it lowers cardiac output and blood pressure, giving the heart a “rest.”

Renin Inhibition: It also reduces the release of renin from the kidneys, further interfering with the blood-pressure-raising RAAS pathway.

The Manufacturer’s Perspective: Formulation & Export

From a production and global trade standpoint, Metoprolol Tartrate 50 mg is a high-volume cardiovascular staple:

  • Tartrate vs. Succinate (The USP): On your digital platforms, it is vital to distinguish between the two. Tartrate is Immediate Release (IR), while Succinate is Extended Release (ER/XL). B2B buyers often look for Tartrate for acute hospital settings or specific twice-a-day titration needs.

  • Scored Tablets: Most 50 mg tablets are produced with a break-line (score). As a WHO-GMP manufacturer, we ensure “Content Uniformity” across the score line, allowing patients to accurately split the tablet into two 25 mg doses if prescribed.

  • Stability & Sensitivity: Metoprolol is sensitive to light and moisture. We utilize Alu-Alu or high-barrier PVC/PVDC blister packaging to ensure a 36-month shelf life for export to Zone IVb regions.

  • Dossier Support: Our Mumbai facility provides full CTD/eCTD Dossiers and bioequivalence data against the innovator (Lopressor) to support your firm’s international registrations.

What is Lisinopril 2.5 mg used for?

In the pharmaceutical industry, Lisinopril 2.5 mg is an ACE (Angiotensin-Converting Enzyme) Inhibitor. As a pharmacist, I view the 2.5 mg strength as the critical “initiation dose.” It is used to carefully start treatment in patients who may be sensitive to blood pressure changes, such as the elderly or those on high-dose diuretics, to avoid a sudden drop in blood pressure (first-dose hypotension).

Primary Clinical Uses

  • Hypertension (High Blood Pressure): Used as a starting dose to gradually lower blood pressure. It is often titrated upward to 10 mg or 20 mg for long-term maintenance.

  • Heart Failure: Administered as an adjunctive therapy to improve survival and reduce hospitalizations by easing the workload on the heart.

  • Post-Myocardial Infarction (Heart Attack): Given within 24 hours of a heart attack to improve hemodynamics and prevent the heart muscle from weakening (remodeling).

  • Diabetic Nephropathy: Prescribed to protect kidney function in diabetic patients by reducing the pressure in the small blood vessels of the kidneys.

Mechanism of Action: The RAAS Pathway

Lisinopril belongs to the dicarboxylic acid-containing group of ACE inhibitors. Unlike many others, it is not a prodrug and does not require liver metabolism to become active.

Enzyme Blockade: It inhibits the enzyme responsible for converting Angiotensin I into Angiotensin II (a powerful vasoconstrictor).

Vasodilation: By reducing Angiotensin II, it allows the blood vessels to relax and widen.

Aldosterone Reduction: It lowers the secretion of aldosterone, which decreases sodium and water retention, thereby reducing the total blood volume.

Kidney Protection: It specifically dilates the efferent arteriole in the kidney, lowering intraglomerular pressure.

The Manufacturer’s Perspective: Technical & Export

From a manufacturing standpoint in a WHO-GMP facility, Lisinopril 2.5 mg presents specific professional requirements:

  • Content Uniformity: Achieving a precise 2.5 mg distribution in a standard-sized tablet requires high-precision blending and validated geometric dilution to ensure every tablet in a batch is therapeutically identical.

  • Stability & Sensitivity: Lisinopril is sensitive to moisture and can undergo cyclization to form diketopiperazine. We utilize Alu-Alu or high-barrier PVC/PVDC blister packaging to ensure a 36-month shelf life for export to Zone IVb regions.

  • Bioequivalence: As a manufacturer, we provide dissolution profiles comparing our generic to the innovator (Zestril or Prinivil) to ensure B2B buyers of its efficacy.

  • Dossier Availability: Our Mumbai facility maintains full CTD/eCTD Dossiers to support rapid product registration in international markets.

What is Imidapril hydrochloride used for?

In the pharmaceutical industry, Imidapril Hydrochloride is a potent, long-acting ACE (Angiotensin-Converting Enzyme) inhibitor. As a pharmacist, I classify this as a “pro-drug”—it is inactive when swallowed and must be metabolized by the liver into its active form, imidaprilat, to exert its therapeutic effect.

Primary Clinical Uses

  • Hypertension (High Blood Pressure): It is primarily used to treat essential hypertension. It is particularly valued because it provides 24-hour blood pressure control with a single daily dose.

  • Congestive Heart Failure (CHF): Used as an adjunctive therapy to reduce the workload on the heart, improving exercise tolerance and long-term outcomes.

  • Renal Protection (Diabetic Nephropathy): Like other ACE inhibitors, it is often prescribed to protect kidney function in diabetic patients by reducing intraglomerular pressure.

    Mechanism of Action

Imidapril works by interrupting the Renin-Angiotensin-Aldosterone System (RAAS), which is the body’s primary regulator of blood pressure.

  1. Enzyme Inhibition: Imidaprilat inhibits the ACE enzyme, which normally converts Angiotensin I into the potent vasoconstrictor Angiotensin II.

  2. Vasodilation: By reducing Angiotensin II levels, blood vessels relax and widen (vasodilation), which lowers peripheral vascular resistance.

  3. Aldosterone Reduction: It also decreases the secretion of aldosterone, leading to reduced sodium and water retention by the kidneys.

  4. Bradykinin Potentiation: It inhibits the breakdown of bradykinin (a vasodilator), further contributing to its blood-pressure-lowering effect.

The Manufacturer’s Perspective: Formulation & Export

From a manufacturing and global trade standpoint, Imidapril is a high-precision cardiovascular product:

  • Low Incidence of “ACE Cough”: Clinical data suggests that Imidapril may have a lower incidence of the persistent dry cough typically associated with other ACE inhibitors (like Enalapril). As a firm owner, this is a major unique selling proposition (USP) for your digital marketing and export proposals.

  • API Stability: Imidapril is sensitive to moisture and heat. As a WHO-GMP manufacturer, we utilize Alu-Alu blister packaging to ensure a 36-month shelf life, which is essential for maintaining efficacy during export to Zone IVb regions (Africa, SE Asia).

  • Fixed-Dose Combinations (FDCs): Imidapril is often manufactured in combination with diuretics like Hydrochlorothiazide. These FDCs are highly sought after in B2B markets for improving patient compliance.

  • Dossier Support: Our Mumbai facility provides the CTD/eCTD Dossiers and stability data required to register this product in international markets against the innovator (Tanatril).

What is Hydrochlorothiazide 25 mg used for?

In the pharmaceutical industry, Hydrochlorothiazide (HCTZ) 25 mg is the most widely used thiazide diuretic. As a pharmacist, I classify this as a “foundational” cardiovascular medication. The 25 mg strength is the standard maintenance dose for the majority of adult patients, offering an optimal balance between blood pressure control and the management of electrolyte levels.

Primary Clinical Uses

  • Hypertension (High Blood Pressure): It is a first-line therapy, either used alone or in combination with other classes (like ACE inhibitors or ARBs). It reduces the risk of stroke and cardiovascular events.

  • Edema: Management of fluid retention associated with Congestive Heart Failure (CHF), hepatic cirrhosis, and various forms of renal dysfunction.

  • Nephrolithiasis (Kidney Stones): Often used off-label to reduce the excretion of calcium in the urine, thereby preventing the formation of calcium oxalate stones.

  • Diabetes Insipidus: Paradoxically used to reduce urine output in patients with the nephrogenic form of this condition.

Mechanism of Action

Hydrochlorothiazide works in the kidneys, specifically targeting the Distal Convoluted Tubule.

NaCl Symporter Inhibition: It blocks the Sodium-Chloride ($Na^+/Cl^-$) symporter on the luminal membrane of the tubule cells.

Increased Excretion: By preventing the reabsorption of these salts, it forces the body to excrete more sodium, chloride, and—crucially—water.

Vascular Resistance: Beyond fluid loss, long-term use of HCTZ is believed to decrease peripheral vascular resistance (relaxing the blood vessels), which further lowers blood pressure.

The Manufacturer’s Perspective: Formulation & Export

From a manufacturing and global trade standpoint, HCTZ 25 mg is a high-volume, high-stability essential product:

  • BCS Class IV Challenges: HCTZ has low solubility and low permeability. As a WHO-GMP manufacturer, we focus on optimized granulation and particle size distribution to ensure the 25 mg tablet meets the strict dissolution requirements of BP/USP/IP.

  • Fixed-Dose Combinations (FDCs): HCTZ is the “king of combinations.” We frequently manufacture it alongside Telmisartan, Losartan, or Amlodipine. For your digital platform, offering these FDCs is essential for capturing the B2B export market.

  • Photosensitivity: HCTZ is slightly light-sensitive. We utilize opaque PVC/PVDC or Alu-Alu blister packaging to ensure a 36-month shelf life, especially for export to Zone IVb regions (Africa and Southeast Asia).

  • B2B & Public Health Tenders: This is a core item for government health programs. Our Mumbai-based facility provides the necessary CTD/eCTD Dossiers to support rapid registration in international markets.

 

 

What is hydralazine 25 mg used for?

In the pharmaceutical industry, Hydralazine Hydrochloride 25 mg is a potent direct-acting peripheral vasodilator. As a pharmacist, I categorize this as a specialized antihypertensive that works exclusively on the smooth muscles of the arterial system rather than the venous system.

Primary Clinical Uses

  • Essential Hypertension: Used as an adjunctive therapy for high blood pressure, typically when first-line agents like ACE inhibitors or Calcium Channel Blockers are insufficient.

  • Hypertensive Emergency/Urgency: Frequently used in hospital settings for the rapid reduction of dangerously high blood pressure.

  • Chronic Heart Failure (CHF): Often used in a specific fixed-dose combination with Isosorbide Dinitrate (particularly in self-identified Black patients) to reduce mortality and hospitalizations.

  • Preeclampsia and Eclampsia: One of the preferred agents for managing severe hypertension during pregnancy due to its established safety profile for the fetus.

Mechanism of Action

Hydralazine works by directly relaxing the smooth muscles of the arterioles.

Vascular Relaxation: It interferes with the movement of calcium ions within the smooth muscle cells of the arterial walls.

Peripheral Resistance Reduction: By causing the arteries to widen (vasodilation), it significantly reduces peripheral vascular resistance.

Blood Pressure Drop: The heart can pump blood more easily against lower resistance, leading to a decrease in systemic blood pressure.

Reflex Tachycardia: Because it causes rapid vasodilation, it often triggers a “reflex” increase in heart rate, which is why it is commonly prescribed alongside a Beta-blocker.

The Manufacturer’s Perspective: Formulation & Export

From a manufacturing and global trade standpoint, Hydralazine 25 mg is a high-precision product with specific technical requirements:

  • API Stability: Hydralazine is susceptible to oxidation and can interact with certain tablet excipients (specifically those containing lactose or certain metals). As a WHO-GMP manufacturer, we utilize stabilized formulations to prevent the formation of “Hydrazones.”

  • Dose Titration: Since patients often start at 10 mg or 25 mg and titrate up to 50 mg, we ensure our 25 mg tablets have high breaking strength and friability standards to allow for precise dosing.

  • Stability for Export: We utilize Alu-Alu blister packaging to protect the API from moisture and light, ensuring a 24–36 month shelf life for export to Zone IVb regions (Africa, SE Asia).

  • B2B & Dossier Support: We provide comprehensive CTD/eCTD Dossiers to support international registration against the innovator (Apresoline). This is a staple for cardiovascular specialty distributors.

Add to cart